Research & Literature

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

Chow EJ, Asselin BL, Schwartz CL, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015; (33(24)):2639-45 doi:10.1200/JCO.2014.59.4473.

Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial.

Beatty L, Koczwara B, Wade T

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016; (24(3)):1043-51 doi:10.1007/s00520-015-2867-6.

Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).

Shkalim-Zemer V, Ash S, Toledano H, et al.

Cancer chemotherapy and pharmacology 2015; (76(5)):909-16 doi:10.1007/s00280-015-2865-x.

Risk-Based Therapy for Localized Osteosarcoma.

Venkatramani R, Murray J, Helman L, et al.

Pediatric blood & cancer 2016; (63(3)):412-7 doi:10.1002/pbc.25808.

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.

Bishop MW, Chang YC, Krailo MD, et al.

Pediatric blood & cancer 2016; (63(10)):1737-43 doi:10.1002/pbc.26034.

UK guidelines for the management of bone sarcomas.

Gerrand C, Athanasou N, Brennan B, et al.

Clinical sarcoma research 2016; (6()):7 doi:10.1186/s13569-016-0047-1.

Follow-up practices for high-grade extremity Osteosarcoma.

Rothermundt C, Seddon BM, Dileo P, et al.

BMC cancer 2016; (16()):301 doi:10.1186/s12885-016-2333-y.

The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.

Machado I, Navarro S, Picci P, Llombart-Bosch A

Pathology, research and practice 2016; (212(9)):811-6.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Marina NM, Smeland S, Bielack SS, et al.

The Lancet. Oncology 2016; (17(10)):1396-1408 doi:10.1016/S1470-2045(16)30214-5.

Osteosarcoma: Accurately diagnosing this bone-chilling disease.

Hiller C, Wegler JL, Forest CP

JAAPA : official journal of the American Academy of Physician Assistants 2016; (29(12)):29-35 doi:10.1097/01.JAA.0000508202.17804.4d.

Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations.

Berger-Richardson D, Swallow CJ

Cancer 2017; (123(4)):560-567 doi:10.1002/cncr.30370.

Advances in the management of osteosarcoma.

Bielack SS, Hecker-Nolting S, Blattmann C, Kager L

F1000Research 2016; (5()):2767 doi:10.12688/f1000research.9465.1.

A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes.

He X, Gao Z, Xu H, et al.

Journal of orthopaedic surgery and research 2017; (12(1)):5 doi:10.1186/s13018-016-0500-0.

Telangiectatic osteosarcoma of the rib: a rare entity and a potential diagnostic pitfall.

Saguem I, Ayadi L, Kallel R, et al.

Pathologica 2016; (108(4)):175-178.

ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.

Park JA, Shin HY

Journal of pediatric hematology/oncology 2017; (39(5)):e270-e274 doi:10.1097/MPH.0000000000000802.

Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center.

Vijayanarasimha D, Nayanar SK, Vikram S, et al.

Indian journal of surgical oncology 2017; (8(2)):136-141 doi:10.1007/s13193-016-0547-8.

Multidisciplinary approach to osteosarcoma.

Biazzo A, De Paolis M

Acta orthopaedica Belgica 2016; (82(4)):690-698.

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.

Ferrari S, Bielack SS, Smeland S, et al.

Tumori 2018; (104(1)):30-36 doi:10.5301/tj.5000696.

Development and validation of nomogram based on miR-203 and clinicopathological characteristics predicting survival after neoadjuvant chemotherapy and surgery for patients with non-metastatic osteosarcoma.

Cheng D, Qiu X, Zhuang M, et al.

Oncotarget 2017; (8(57)):96935-96944 doi:10.18632/oncotarget.18534.

Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.

Baldauf MC, Orth MF, Dallmayer M, et al.

Oncotarget 2018; (9(2)):1587-1601 doi:10.18632/oncotarget.20098.

Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling.

Reichardt P, Tabone MD, Mora J, et al.

Future oncology (London, England) 2018; (14(25)):2663-2676 doi:10.2217/fon-2018-0210.

Current questions in bone sarcomas.

Strauss SJ, Whelan JS

Current opinion in oncology 2018; (30(4)):252-259 doi:10.1097/CCO.0000000000000456.

Postoperative Imaging of Sarcomas.

Tavare AN, Robinson P, Altoos R, et al.

AJR. American journal of roentgenology 2018; (211(3)):506-518 doi:10.2214/AJR.18.19954.

Understanding osteosarcomas.

Simpson E, Brown HL

JAAPA : official journal of the American Academy of Physician Assistants 2018; (31(8)):15-19 doi:10.1097/01.JAA.0000541477.24116.8d.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, et al.

BMC musculoskeletal disorders 2018; (19(1)):297 doi:10.1186/s12891-018-2217-1.

Bone Cancer: Diagnosis and Treatment Principles.

Ferguson JL, Turner SP

American family physician 2018; (98(4)):205-213.

Osteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes.

Nie Z, Peng H

Oncology letters 2018; (16(5)):6502-6514 doi:10.3892/ol.2018.9453.

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.

Clemens E, van den Heuvel-Eibrink MM, Mulder RL, et al.

The Lancet. Oncology 2019; (20(1)):e29-e41 doi:10.1016/S1470-2045(18)30858-1.

Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study.

Huang X, Zhao J, Bai J, et al.

Journal of bone oncology 2019; (16()):100230 doi:10.1016/j.jbo.2019.100230.

Surgery in reference centers improves survival of sarcoma patients: a nationwide study.

Blay JY, Honoré C, Stoeckle E, et al.

Annals of oncology : official journal of the European Society for Medical Oncology 2019; (30(7)):1143-1153 doi:10.1093/annonc/mdz124.

The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy.

Liu Y, Wang X, Wang G, et al.

European journal of medicinal chemistry 2019; (176()):92-104 doi:10.1016/j.ejmech.2019.05.018.

RB1 Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression.

Marshall AE, Roes MV, Passos DT, et al.

Molecular and cellular biology 2019; (39(16)) doi:10.1128/MCB.00105-19.

Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.

Knudsen ES, Pruitt SC, Hershberger PA, et al.

Trends in cancer 2019; (5(5)):308-324 doi:10.1016/j.trecan.2019.03.005.

Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.

Huang R, Xian S, Shi T, et al.

Medical science monitor : international medical journal of experimental and clinical research 2019; (25()):4675-4690 doi:10.12659/MSM.915418.

Clinical evaluation of neoadjuvant chemotherapy for osteosarcoma.

Zhu W, Zhu L, Bao Y, et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2019; (24(3)):1181-1185.

The Rich World of p53 DNA Binding Targets: The Role of DNA Structure.

Brázda V, Fojta M

International journal of molecular sciences 2019; (20(22)) doi:10.3390/ijms20225605.

The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.

Barnett JR, Gikas P, Gerrand C, et al.

Skeletal radiology 2020; (49(6)):913-919 doi:10.1007/s00256-019-03364-0.

How Technology Is Improving the Multidisciplinary Care of Sarcoma.

Schaefer IM, Hong K, Kalbasi A

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2020; (40()):445-462 doi:10.1200/EDBK_280729.

Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.

Bhagat A, Kleinerman ES

Advances in experimental medicine and biology 2020; (1257()):181-192 doi:10.1007/978-3-030-43032-0_15.

Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity.

Ma W, Wei S, Zhang B, Li W

Frontiers in cell and developmental biology 2020; (8()):434 doi:10.3389/fcell.2020.00434.

Follow-Up in Bone Sarcoma Care: A Cross-Sectional European Study.

Goedhart LM, Leithner A, Ploegmakers JJW, Jutte PC

Sarcoma 2020; (2020()):2040347 doi:10.1155/2020/2040347.

Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis.

Papakonstantinou E, Stamatopoulos A, I Athanasiadis D, et al.

Journal of bone oncology 2020; (25()):100319 doi:10.1016/j.jbo.2020.100319.

Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data.

Schoffer O, Roessler M, Datzmann T, et al.

Oncology research and treatment 2021; (44(3)):103-110 doi:10.1159/000513178.

The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma.

Araki Y, Yamamoto N, Hayashi K, et al.

Scientific reports 2021; (11(1)):1989 doi:10.1038/s41598-020-80504-w.

Recent Advances in p53.

D'Orazi G

Biomolecules 2021; (11(2)) doi:10.3390/biom11020211.

Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.

Prabowo Y, Setiawan I, Kamal AF, et al.

International journal of surgical oncology 2021; (2021()):8843325 doi:10.1155/2021/8843325.

Do Not Miss the Tumor: A Novel Presentation of Osteosarcoma.

DePalma M, Gupta S, Nguyen J, et al.

Case reports in pediatrics 2021; (2021()):5531238 doi:10.1155/2021/5531238.

Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey.

Bui KT, Kiely BE, Dhillon HM, et al.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (30(1)):511-519 doi:10.1007/s00520-021-06454-9.

The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response.

Cascini C, Chiodoni C

Cells 2021; (10(7)) doi:10.3390/cells10071668.

Percutaneous Core Needle Biopsy Can Efficiently and Safely Diagnose Most Primary Bone Tumors.

Crenn V, Vezole L, Bouhamama A, et al.

Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091552.

Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol.

Suárez-Mattos A, Arroyave F, Infante AM, et al.

Boletin medico del Hospital Infantil de Mexico 2022; (79(1)):17-25 doi:10.24875/BMHIM.21000087.

Limb salvage surgery has a higher complication rate than amputation but is still beneficial for patients younger than 10 years old with osteosarcoma of an extremity.

Kaneuchi Y, Yoshida S, Fujiwara T, et al.

Journal of pediatric surgery 2022; (57(11)):702-709 doi:10.1016/j.jpedsurg.2022.04.001.

Surgical Treatment of Bone Sarcoma.

Bläsius F, Delbrück H, Hildebrand F, Hofmann UK

Cancers 2022; (14(11)) doi:10.3390/cancers14112694.

Ultrasound-Guided Trans-Uterine Cavity Core Needle Biopsy of Uterine Myometrial Tumors to Differentiate Sarcoma from a Benign Lesion-Description of the Method and Review of the Literature.

Stukan M, Rutkowski P, Smadja J, Bonvalot S

Diagnostics (Basel, Switzerland) 2022; (12(6)) doi:10.3390/diagnostics12061348.

Role of extracellular vesicles in osteosarcoma.

Yang Q, Liu J, Wu B, et al.

International journal of medical sciences 2022; (19(8)):1216-1226 doi:10.7150/ijms.74137.

Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.

Xu B, Viswanathan K, Umrau K, et al.

Histopathology 2022; (81(5)):670-679 doi:10.1111/his.14772.

Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions.

Tian D, Feng K, Wu X, et al.

Evidence-based complementary and alternative medicine : eCAM 2022; (2022()):6510429 doi:10.1155/2022/6510429.

Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

de Baat EC, van Dalen EC, Mulder RL, et al.

The Lancet. Child & adolescent health 2022; (6(12)):885-894 doi:10.1016/S2352-4642(22)00239-5.

Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer.

Mercan C, Balkenhol M, Salgado R, et al.

NPJ breast cancer 2022; (8(1)):120 doi:10.1038/s41523-022-00488-w.

Osteosarcoma.

Beird HC, Bielack SS, Flanagan AM, et al.

Nature reviews. Disease primers 2022; (8(1)):77 doi:10.1038/s41572-022-00409-y.

Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment.

Goedhart LM, Ho VKY, Ploegmakers JJW, et al.

Journal of bone oncology 2023; (38()):100466 doi:10.1016/j.jbo.2022.100466.

Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

Derry-Vick HM, Heathcote LC, Glesby N, et al.

Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.

Baněčková M, Thompson LDR, Hyrcza MD, et al.

The American journal of surgical pathology 2023; (47(6)):661-677 doi:10.1097/PAS.0000000000002043.

An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1.

Qin A

Frontiers in oncology 2023; (13()):1173467 doi:10.3389/fonc.2023.1173467.

Are Pathologic Fractures in Patients With Osteosarcoma Associated With Worse Survival Outcomes? A Systematic Review and Meta-analysis.

Gonzalez MR, Bedi A, Karczewski D, Lozano-Calderon SA

Clinical orthopaedics and related research 2023; (481(12)):2433-2443 doi:10.1097/CORR.0000000000002687.

Needle tract seeding of a sclerosing epithelioid fibrosarcoma in a biopsy tract: a case report.

Kawai M, Miwa S, Yamamoto N, et al.

BMC musculoskeletal disorders 2023; (24(1)):454 doi:10.1186/s12891-023-06553-0.

Surgery at specialised sarcoma centres improves patient outcomes - A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.

Hong AM, Sundaram A, Perianayagam G, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2023; (49(9)):106951 doi:10.1016/j.ejso.2023.06.003.

Systemic cisplatin increases the number of patients showing positive off-frequency masking audiometry.

Hiraumi H, Oikawa SI, Shiga K, Sato H

PloS one 2023; (18(7)):e0287400 doi:10.1371/journal.pone.0287400.

Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Mavinkurve-Groothuis AMC, de Baat EC, Feijen EAM, et al.

Pediatric blood & cancer 2023; (70(10)):e30604 doi:10.1002/pbc.30604.

Assessment of the Interval to Diagnosis in Pediatric Bone Sarcoma.

Kha ST, Sharma J, Kenney D, et al.

Pediatric emergency care 2023; (39(12)):963-967 doi:10.1097/PEC.0000000000003031.

Scan-Associated Distress in People Affected by Cancer: A Qualitative Systematic Review.

Hussain M, Chau S, Turner M, Paterson C

Seminars in oncology nursing 2023; (39(5)):151502 doi:10.1016/j.soncn.2023.151502.

Telangiectatic osteosarcoma of maxilla in a young child.

Jot K, Nayyar V, Manchanda S, et al.

Oral oncology 2023; (147()):106605 doi:10.1016/j.oraloncology.2023.106605.

Fibroblastic osteosarcoma: A perplexing entity.

Kaur KP, Kundu S, Chatterjee A, Pal M

Journal of oral and maxillofacial pathology : JOMFP 2023; (27(3)):573-578 doi:10.4103/jomfp.jomfp_496_22.

Does an excision of needle bone biopsy tract affect the prognosis in patients with primary bone tumor?

Gami A, Shah A, Shankaralingappa S, et al.

Journal of orthopaedics 2024; (48()):13-19 doi:10.1016/j.jor.2023.11.039.

Is Unplanned Excision of Soft Tissue Sarcomas Associated with Worse Oncological Outcomes?-A Systematic Review and Meta-Analysis.

Larios F, Gonzalez MR, Ruiz-Arellanos K, et al.

Cancers 2024; (16(2)) doi:10.3390/cancers16020443.

The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma.

Brekke SG, Lucke A, Hasle H, Baad-Hansen T

Pediatric hematology and oncology 2024; (41(4)):273-282 doi:10.1080/08880018.2024.2311407.

A Humeral Osteosarcoma Mimicking Osseous Leiomyosarcoma: A Case Report.

Yan Y, Xie V, Perrin D, et al.

Cureus 2024; (16(1)):e52469 doi:10.7759/cureus.52469.

Patterns and treatment outcomes of primary bone tumors in children treated at tertiary referral hospital, Ethiopia.

Lingerih T, Yeshiwas S, Mohamedsaid A, Arega G

BMC cancer 2024; (24(1)):394 doi:10.1186/s12885-024-12169-x.

Evaluating the Outcome and Patient Safety of Methotrexate, Doxorubicin, and Cisplatin Regimen for Chemotherapy in Osteosarcoma: A Meta-Analysis.

Ismail MD, Wiratnaya IGE, Raditya RH

Asian Pacific journal of cancer prevention : APJCP 2024; (25(5)):1497-1505 doi:10.31557/APJCP.2024.25.5.1497.

Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).

Becktell K, Chen Y, Yasui Y, et al.

Pediatric blood & cancer 2024; (71(10)):e31189 doi:10.1002/pbc.31189.

Osteosarcoma Metastasis to the Thorax: A Pictorial Review of Chest Computed Tomography Findings.

Alduraibi KA, Towhari JA, Alebdi HA, et al.

Diagnostics (Basel, Switzerland) 2024; (14(18)) doi:10.3390/diagnostics14182085.

Limb Salvage Surgery in Pediatric Patients with Osteosarcoma.

Niculescu ȘA, Grecu AF, Gheonea C, Grecu DC

Current health sciences journal 2024; (50(3)):360-367 doi:10.12865/CHSJ.50.03.03.

Multimodal Imaging of Osteosarcoma: From First Diagnosis to Radiomics.

Cè M, Cellina M, Ueanukul T, et al.

Cancers 2025; (17(4)) doi:10.3390/cancers17040599.

Incidence and age- and site-specific characteristics of osteosarcoma: a population-based study using National Cancer Registry 2016-2019.

Ogura K, Morizane C, Satake T, et al.

Japanese journal of clinical oncology 2025; (55(9)):1037-1045 doi:10.1093/jjco/hyaf086.

SATB2 immunohistochemistry in osteosarcoma: Utility in diagnosis and differentiation from histologic mimics.

Gangula S, Hui M, Uppin SG, et al.

Indian journal of pathology & microbiology 2025; (68(3)):518-525 doi:10.4103/ijpm.ijpm_631_24.

Challenges in Diagnosing Diaphyseal Osteosarcoma - Importance of Strong Clinical Suspicion and Biopsy Technique: An Illustrative Case Report.

Balaji V, Tavfiq M, Balasubramanian S, et al.

Journal of orthopaedic case reports 2025; (15(8)):184-190 doi:10.13107/jocr.2025.v15.i08.5934.

Cardiovascular toxicity in testicular germ cell tumor survivors.

Orszaghova Z, Mladosievicova B, Mego M, Chovanec M

Frontiers in oncology 2025; (15()):1654063 doi:10.3389/fonc.2025.1654063.

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis.

Liu X, Ding R, Zhang A

Frontiers in cardiovascular medicine 2025; (12()):1612060 doi:10.3389/fcvm.2025.1612060.

Time to treatment initiation in primary extremity sarcomas: Determinants and oncological outcomes in a tertiary LMIC cancer center.

Murali A, Krishnan CK, Patel V, et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(11)):110449 doi:10.1016/j.ejso.2025.110449.

Beyond ejection fraction: cardiac magnetic resonance imaging in anthracycline cardiotoxicity.

Motevalli M, Deilami T, Kia YM, et al.

BMC medical imaging 2025; (25(1)):478 doi:10.1186/s12880-025-02027-y.

Efferocytosis-associated transcriptomic patterns characterize prognosis and immune landscape in osteosarcoma.

Song X, Tou X, Li L, et al.

Journal of bone oncology 2026; (57()):100743 doi:10.1016/j.jbo.2026.100743.

Long-term Outcomes of 3-dimensional-printed Cutting Guides for Long Bone Sarcoma Resection and Intercalary Allograft Reconstruction: An Updated Case Series.

Butler ZR, Riley DJ, Gusho CA, et al.

Orthopedics 2026; (49(1)):e76-e82 doi:10.3928/01477447-20260106-02.

Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects.

Zia B, Nagoor Meeran MF, Sharma C, et al.

European journal of pharmacology 2026; (1017()):178646 doi:10.1016/j.ejphar.2026.178646.

PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.

do Couto FB, Yonamine ES, Magno FG, et al.

Acta ortopedica brasileira 2026; (34(1)):e293900 doi:10.1590/1413-785220263401e293900.

A Tumor-Bearing Mouse Model of Cisplatin-Induced Hearing Loss for Preclinical Otoprotectant Evaluation.

Li X, Mao H, Feng M, et al.

Hearing research 2026; (477()):109657 doi:10.1016/j.heares.2026.109657.